PLA2G4A and glioblastoma: However, the role of cPLA2 is highly controversial, and some studies also elucidated its implication via its phosphorylation in the anti-tumor effects of temozolomide (TMZ), the alkylating agent used as the first line of treatment for glioblastoma [32].